Navigation Links
Beckman Coulter Completes Acquisition of Olympus' Lab-Based Diagnostics Business
Date:8/2/2009

ORANGE COUNTY, Calif., Aug. 2 /PRNewswire-FirstCall/ -- Beckman Coulter, Inc. (NYSE: BEC), a leading developer, manufacturer and marketer of products that simplify, automate and innovate complex biomedical testing, announced today the completion of the acquisition of Olympus' lab-based diagnostics business. This acquisition, first announced in February, extends Beckman Coulter's leadership position in Chemistry and Automation.

(Logo: http://www.newscom.com/cgi-bin/prnh/20031202/BECLOGO )

Scott Garrett, chairman, president and chief executive officer, said, "The completion of this transaction adds considerable product depth and significantly expands our geographic reach and scale. We are confident that the combination of Olympus diagnostics with our business will provide many cross-selling opportunities -- the most compelling being promotion of Beckman Coulter's leading Immunoassay products to the loyal base of Olympus' chemistry customers.

"We remain focused on creating shareholder value through growth, quality and operating excellence. This acquisition demonstrates Beckman Coulter's commitment to further extend our leadership position in chemistry and sustain our above-market growth in immunoassay," concluded Garrett.

Beckman Coulter delivered approximately 76 billion Japanese yen in cash, or approximately USD $780 million, which was funded as follows:

  • Approximately $495 million in net proceeds raised from the issuance of two $250 million senior note offerings of 6- and 10- year maturities with 6% and 7% coupons, respectively.
  • Approximately $240 million in a commo
    '/>"/>

SOURCE Beckman Coulter, Inc.
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2

Related biology technology :

1. Beckman Coulter to Present at the Bear Stearns Healthcare Conference
2. Beckman Coulter to Present at the UBS Global Life Sciences Conference
3. Beckman Coulter Announces Third Quarter 2007 Earnings to Be Released on Tuesday, October 30, 2007 Before Market Opens
4. Beckman Coulter Declares Quarterly Dividend
5. Beckman Coulter Announces Third Quarter 2007 Results
6. Beckman Coulter to Present at the 19th Annual Piper Jaffray Healthcare Conference
7. Beckman Coulter to Present at the Lazard Capital Markets Fourth Annual Healthcare Conference
8. Beckman Coulter to Acquire Exclusive Rights to Break-Through Technologies
9. Beckman Coulter Elects AMN Healthcare Executive to Board of Directors
10. Beckman Coulter to Present at the JPMorgan Healthcare Conference
11. AcroMetrix Signs Development and Supply Agreement With Beckman Coulter Inc. for Molecular Quality Control Standards
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/21/2012)... May 21, 2012 Genesis Biopharma, Inc. ... immunotherapies, announces the posting of the following Letter ... Company,s website at www.genesis-biopharma.com .  In addition, ... the U.S. Securities and Exchange Commission its Quarterly ... 2012 on Form 10-Q.  The Form 10-Q includes ...
(Date:5/18/2012)... DIEGO, May 18, 2012 Sequenom, Inc. (NASDAQ: ... innovative genetic analysis solutions, today announced that a new ... study on the Sequenom Center for Molecular Medicine,s (Sequenom ... been published online in the peer-reviewed journal, Prenatal ... announces that as of the week ended May 12, ...
(Date:5/16/2012)... 2011, nearly fifteen years after she became paralyzed and ... by thinking about moving her arm and hand to ... take a drink. That achievement is one of the ... technology described in the May 17 edition of the ... researchers at the Department of Veterans Affairs, Brown University, ...
(Date:5/16/2012)... ANAHEIM, Calif., May 16, 2012  Questcor Pharmaceuticals, ... that its Board of Directors has increased the ... additional 5 million shares. Since the ... million to shareholders through the repurchase of approximately ... 27% of its shares as of the commencement ...
Breaking Biology Technology:Genesis Biopharma Issues Letter To Shareholders 2Genesis Biopharma Issues Letter To Shareholders 3Genesis Biopharma Issues Letter To Shareholders 4Study In Prenatal Diagnosis Finds Sequenom CMM's MaterniT21™ PLUS Lab-developed Test Accurately Detects Fetal Trisomies In Pregnant Women Carrying Twins Or Triplets 2Study In Prenatal Diagnosis Finds Sequenom CMM's MaterniT21™ PLUS Lab-developed Test Accurately Detects Fetal Trisomies In Pregnant Women Carrying Twins Or Triplets 3Study In Prenatal Diagnosis Finds Sequenom CMM's MaterniT21™ PLUS Lab-developed Test Accurately Detects Fetal Trisomies In Pregnant Women Carrying Twins Or Triplets 4Study In Prenatal Diagnosis Finds Sequenom CMM's MaterniT21™ PLUS Lab-developed Test Accurately Detects Fetal Trisomies In Pregnant Women Carrying Twins Or Triplets 5People with paralysis control robotic arms to reach and grasp using brain computer interface 2People with paralysis control robotic arms to reach and grasp using brain computer interface 3People with paralysis control robotic arms to reach and grasp using brain computer interface 4People with paralysis control robotic arms to reach and grasp using brain computer interface 5Questcor Pharmaceuticals Expands Repurchase Program 2Questcor Pharmaceuticals Expands Repurchase Program 3Questcor Pharmaceuticals Expands Repurchase Program 4Questcor Pharmaceuticals Expands Repurchase Program 5
... CHAPEL HILL, N.C., June 18 To thrive ... need to,understand that a winning sales performance doesn,t ... their sales forces, then,measure the forces, field-performance to ... research study reveals that best-in-class,companies allow their sales ...
... Inc. (OTC Bulletin Board: SYVC), a specialty,pharmaceutical company, ... LLC (Kirk) during the past year has added ... clients that includes Target,Walgreens, Family Dollar, HEB and ... are all over-the-counter (OTC) private label or "store,brand" ...
... CHESHIRE, Conn., June 18 Alexion,Pharmaceuticals, Inc. (Nasdaq: ... Officer of Alexion Pharmaceuticals, will present at the,Jefferies & ... at 4:15,p.m., ET on Wednesday, June 25, 2008., ... available live. You can,access the webcast at: http://www.alexionpharm.com ...
Other Biology Technology:Increasing Sales Productivity Through Superior Sales Force Performance Management 2Synovics Pharmaceuticals Announces Continued Growth of Customer Relationships 2Synovics Pharmaceuticals Announces Continued Growth of Customer Relationships 3Synovics Pharmaceuticals Announces Continued Growth of Customer Relationships 4Synovics Pharmaceuticals Announces Continued Growth of Customer Relationships 5
(Date:5/21/2012)... Purdue University are working with the U.S. Army ... Center to create a new type of "bioactive" coating ... caused by head trauma from bomb blasts. , "Stents ... the site of an aneurism to help heal the ... Allain, an associate professor of nuclear engineering. "Aneurisms are ...
(Date:5/21/2012)... mercury in plants and animals, a new study by ... Aquarium has compared levels of the chemical in captive ... animals were fed a controlled diet, while the wild ... of the toxic metal., The study found lower levels ... wild dolphins tested off the Atlantic and Gulf coasts ...
(Date:5/21/2012)... a combination of cues in their hunting sequence - capture, ... catch and consume and which ones they are better off ... first listen to their prey, then they assess its size, ... Page and her team from the Smithsonian Tropical Research Institute ... - The Science of Nature . , To survive, predators ...
Breaking Biology News(10 mins):Purdue professor to speak before Congress about nanotechnology in brain treatment research 2Purdue professor to speak before Congress about nanotechnology in brain treatment research 3Mercury in dolphins: Study compares toxin levels in captive and wild sea mammals 2Mercury in dolphins: Study compares toxin levels in captive and wild sea mammals 3What sounds good doesn't always taste good 2Henry Ford physicist awarded for cancer radiation therapy research 76678 1Henry Ford physicist awarded for cancer radiation therapy research 76678 2Study identifies flaws in Medicare prescription drug program 76676 1Study identifies flaws in Medicare prescription drug program 76676 2American Chemical Society co hosts Science and Society discussion on food safety on Nov 1 76674 1American Chemical Society co hosts Science and Society discussion on food safety on Nov 1 76674 2
... A study of populations of tiny water fleas is ... predictions about the ecological consequences of environmental change. , The ... Nature . The water flea, called Daphnia, plays a key ... Roger Nisbet, an ecologist based at the University of California, ...
... 30, 2008) The world,s rarest big cat is alive ... according to researchers from the Wildlife Conservation Society (WCS) who ... last week., The capture was made in Primorsky Krai along ... and the Russian Academy of Sciences Institute of Biology and ...
... in developing a water treatment system for industrial oil ... other commercially available tertiary treatments, leaving water so clean ... without endangering flora or fauna. , Wastewater from ships, ... with toxic compounds. Stringent EU regulations apply to its ...
Other Biology News:Studies of small water fleas help ecologists understand population dynamics 2World's rarest big cat gets a check-up 2World's rarest big cat gets a check-up 3Cleaning heavily polluted water at a fraction of the cost 2Cleaning heavily polluted water at a fraction of the cost 3
adult...
Porcine Serum Available Anticoagulants: N-02: Citrate N-04: Heparin (Na) N-06: K2EDTA N-08: Potassium Oxalate N-10: EDTA (Na) N-03: Alsevers N-05: ACD N-07: CPD N-09: K3EDTA N-11...
... Guinea Pig serum is collected from fasted Guinea ... Citrate N-04: Heparin (Na) ... N-10: EDTA (Na) N-03: ... CPD N-09: K3EDTA N-11: ...
EPH electrode, anode, 1. Category: Electrophoresis Systems & Standards & Reagents, IEF & SDS-PAGE & 2-D Electrophoresis, Multiphor II Kits & Components and Accessories....
Biology Products: